Biotech / Finance

AVXS Abuzz, PTCT Slammed For Emflaza Deal, INNL Scouts For Buyer

From RTT - Biotech
March 17, 2017 - 2:23am
Shares of AveXis Inc. were up more than 11\% in extended trading on Thursday, following the completion of its phase I clinical study of AVXS-101, the first ever gene therapy studied for the treatment of spinal muscular atrophy Type 1.

Continue reading this article »